Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup.
It was patented in 1966 and came into medical use in 1979.[1]
^Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 544. ISBN 9783527607495.
Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered...
amitriptyline. Ambroxol is a lysosomotropic drug of clinical use to treat conditions of productive cough for its mucolytic action. Ambroxol triggers the...
experimental technique of gene therapy may offer cures in the future. Ambroxol has recently been shown to increase activity of the lysosomal enzyme glucocerebrosidase...
the airways, lungs, bronchi, and trachea. Examples are carbocisteine, ambroxol, and bromhexine. Expectorants are substances claimed to make coughing easier...
severe cases of ongoing neuropathic pain it is delivered intrathecally. Ambroxol is a drug that reduces mucus. Preclinical research suggests it may produce...
nimesulide as Zitroflam; in a combination with tinidazole and fluconazole as Trivafluc, and in a combination with ambroxol as Zathrin-AX, Laz-AX and Azro-AM....
combination drug formulations with pseudoephedrine, paracetamol, betamethasone, ambroxol, salbutamol, phenylephrine, and dexamethasone. The marketing of the Claritin...
be potentiated by isoniazid (through inhibiting mycolate synthesis) and ambroxol (through host directed effects in autophagy and pharmacokinetics). Rifampicin...
calcium channels. In contrast to Bay K8644, which is not for clinical use, ambroxol is a frequently used mucolytic drug that triggers lysosomal secretion by...
to other muco-regulatory drugs (such as N-acetylcysteina, sobrerol and ambroxol). Chronic Obstructive Pulmonary Disease Evidence obtained in patients with...
aim to reduce brain levels of alpha-synuclein (with the pharmaceuticals ambroxol, NPT200-11, and E2027), or to use immunotherapy to reduce widespread neuroinflammation...
disease-modifying treatments for Parkinson's. LCT has supported trials in ambroxol, exenatide, simvastatin, liraglutide, and others. In October, the institute...
reduced cytopathic effects, quantitative RT-PCR and plaque forming units. Ambroxol is another drug that has beneficial effects in Vero E6 cells. A comprehensive...
Global Information
(what is this?) (verify)